These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22171322)

  • 1. Stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomics study of a thyroid hormone-regulated secretome in human hepatoma cells.
    Chen CY; Chi LM; Chi HC; Tsai MM; Tsai CY; Tseng YH; Lin YH; Chen WJ; Huang YH; Lin KH
    Mol Cell Proteomics; 2012 Apr; 11(4):M111.011270. PubMed ID: 22171322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive regulation of spondin 2 by thyroid hormone is associated with cell migration and invasion.
    Liao CH; Yeh SC; Huang YH; Chen RN; Tsai MM; Chen WJ; Chi HC; Tai PJ; Liao CJ; Wu SM; Cheng WL; Pai LM; Lin KH
    Endocr Relat Cancer; 2010 Mar; 17(1):99-111. PubMed ID: 19903741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid hormone enhanced human hepatoma cell motility involves brain-specific serine protease 4 activation via ERK signaling.
    Chen CY; Chung IH; Tsai MM; Tseng YH; Chi HC; Tsai CY; Lin YH; Wang YC; Chen CP; Wu TI; Yeh CT; Tai DI; Lin KH
    Mol Cancer; 2014 Jul; 13():162. PubMed ID: 24980078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid hormone promotes cell invasion through activation of furin expression in human hepatoma cell lines.
    Chen RN; Huang YH; Lin YC; Yeh CT; Liang Y; Chen SL; Lin KH
    Endocrinology; 2008 Aug; 149(8):3817-31. PubMed ID: 18467449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis.
    Marquard S; Thomann S; Weiler SME; Bissinger M; Lutz T; Sticht C; Tóth M; de la Torre C; Gretz N; Straub BK; Marquardt J; Schirmacher P; Breuhahn K
    Cell Commun Signal; 2020 Oct; 18(1):166. PubMed ID: 33097058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor.
    Zheng Q; Tang ZY; Xue Q; Shi DR; Song HY; Tang HB
    J Cancer Res Clin Oncol; 2000 Nov; 126(11):641-6. PubMed ID: 11079728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin H regulated by the thyroid hormone receptors associate with tumor invasion in human hepatoma cells.
    Wu SM; Huang YH; Yeh CT; Tsai MM; Liao CH; Cheng WL; Chen WJ; Lin KH
    Oncogene; 2011 Apr; 30(17):2057-69. PubMed ID: 21217776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of microRNA-130b by thyroid hormone enhances cell motility.
    Lin YH; Wu MH; Liao CJ; Huang YH; Chi HC; Wu SM; Chen CY; Tseng YH; Tsai CY; Chung IH; Tsai MM; Chen CY; Lin TP; Yeh YH; Chen WJ; Lin KH
    J Hepatol; 2015 Jun; 62(6):1328-40. PubMed ID: 25617495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma.
    Chen RN; Huang YH; Yeh CT; Liao CH; Lin KH
    Cancer Res; 2008 Mar; 68(6):1697-706. PubMed ID: 18339849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells.
    Liao CH; Yeh CT; Huang YH; Wu SM; Chi HC; Tsai MM; Tsai CY; Liao CJ; Tseng YH; Lin YH; Chen CY; Chung IH; Cheng WL; Chen WJ; Lin KH
    Hepatology; 2012 Mar; 55(3):910-20. PubMed ID: 21994129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer.
    Chung IH; Chen CY; Lin YH; Chi HC; Huang YH; Tai PJ; Liao CJ; Tsai CY; Lin SL; Wu MH; Chen CY; Lin KH
    Oncotarget; 2015 Jun; 6(17):15050-64. PubMed ID: 25940797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormone receptor inhibits hepatoma cell migration through transcriptional activation of Dickkopf 4.
    Chi HC; Liao CH; Huang YH; Wu SM; Tsai CY; Liao CJ; Tseng YH; Lin YH; Chen CY; Chung IH; Wu TI; Chen WJ; Lin KH
    Biochem Biophys Res Commun; 2013 Sep; 439(1):60-5. PubMed ID: 23958302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion.
    Barderas R; Mendes M; Torres S; Bartolomé RA; López-Lucendo M; Villar-Vázquez R; Peláez-García A; Fuente E; Bonilla F; Casal JI
    Mol Cell Proteomics; 2013 Jun; 12(6):1602-20. PubMed ID: 23443137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative secretome analysis reveals the interactions between epithelia and tumor cells by in vitro modulating colon cancer microenvironment.
    Zeng X; Yang P; Chen B; Jin X; Liu Y; Zhao X; Liang S
    J Proteomics; 2013 Aug; 89():51-70. PubMed ID: 23748022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of naturally occurring dominant negative mutants of thyroid hormone alpha 1 and beta 1 receptors in a human hepatocellular carcinoma cell line.
    Lin KH; Zhu XG; Shieh HY; Hsu HC; Chen ST; McPhie P; Cheng SY
    Endocrinology; 1996 Oct; 137(10):4073-81. PubMed ID: 8828459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired interaction of mutant thyroid hormone receptors associated with human hepatocellular carcinoma with transcriptional coregulators.
    Lin KH; Wu YH; Chen SL
    Endocrinology; 2001 Feb; 142(2):653-62. PubMed ID: 11159836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative modulation of the epigenetic regulator, UHRF1, by thyroid hormone receptors suppresses liver cancer cell growth.
    Wu SM; Cheng WL; Liao CJ; Chi HC; Lin YH; Tseng YH; Tsai CY; Chen CY; Lin SL; Chen WJ; Yeh YH; Huang CY; Chen MH; Yeh YC; Lin KH
    Int J Cancer; 2015 Jul; 137(1):37-49. PubMed ID: 25430639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma.
    Ren F; Wu H; Lei Y; Zhang H; Liu R; Zhao Y; Chen X; Zeng D; Tong A; Chen L; Wei Y; Huang C
    Mol Cancer; 2010 Apr; 9():81. PubMed ID: 20403181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid hormone receptor represses miR-17 expression to enhance tumor metastasis in human hepatoma cells.
    Lin YH; Liao CJ; Huang YH; Wu MH; Chi HC; Wu SM; Chen CY; Tseng YH; Tsai CY; Chung IH; Wu TI; Tsai MM; Lin CD; Lin KH
    Oncogene; 2013 Sep; 32(38):4509-18. PubMed ID: 23912452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory role of plasminogen activator inhibitor-1 in invasion and proliferation of HLE hepatocellular carcinoma cells.
    Morita Y; Hayashi Y; Kanamaru T; Itoh T; Suzuki S; Yamamoto M; Kuroda Y; Itoh H
    Jpn J Cancer Res; 1999 Jul; 90(7):747-52. PubMed ID: 10470287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.